• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: nectin-4-targeting polypeptide conjugated to MMAE
Date Designated: 04/25/2025
Orphan Designation: treatment of esophageal cancer
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
ConjuStar (Zhuhai) Biologics Co., Ltd.
Room 301-1, Unit 1, 3rd Floor, Building 18, No. 111 Yaoguan Road
Sanzao Town, Jinwan District
Zhuhai City, Guangdong Province
China

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-